North Carolina At Chapel Hill

With diabetes being such a complex clinical and public health issue, University of North Carolina at Chapel Hill’s School of Medicine has taken an interdisciplinary approach to become a leader type I and type II diabetes research and clinical care. UNC was ranked 6th in federal research dollars in the U.S. in 2017, as well as having 6 basic science departments in the top ten for NIH funding. From the development of drug delivery systems such as the “smart insulin” patch to leading worldwide clinical trials, UNC is making itself known around the world as a top-tier research institution. This research strength coupled with its strong emphasis in collaboration enables UNC to make life-changing discoveries for people living with diabetes.